Hannover-II Scoring System for Classifying a Sentinel Lymph Node from a Patient with Malignant Melanoma

Description

Meier et al developed the Hannover II scoring system for evaluating the findings from a sentinel lymph node biopsy performed on a patient with malignant melanoma. This can help to identify a patient who may benefit from a more aggressive or novel therapy. The authors are from the Hannover Medical School in Germany.

Parameters:

(1) maximum dimension of largest deposit in mm

(2) involvement of capsule (expansion of melanoma cells into the lymph node capsule)

(3) maximum tumor penetration depth in mm

Maximum Dimension	Involvement of Capsule	Maximum Tumor Penetration	Group
0 (negative)	NA	NA	1
< 0.1 mm	NA	NA	1
>= 0.1 mm	absent	<= 2 mm	2
>= 0.1 mm	present	<= 2 mm	2
>= 0.1 mm	absent	> 2 mm	2
>= 0.1 mm	present	> 2 mm	3

Group	Prognosis	Overall Survival at 8 Years (96 Months)
1	fair	80%
2	intermediate (guarded)	64%
3	poor	30%

To read more or access our algorithms and calculators, please log in or register.

Hannover-II Scoring System for Classifying a Sentinel Lymph Node from a Patient with Malignant Melanoma

Description

Specialty